In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a vasopeptidase inhibitor, BMS189921.

被引：0
|
作者：
Burrell, L
Hubner, R
Powell, J
Johnston, C
机构：
[1] Univ Melbourne, Austin & Repat Med Ctr, Heidelberg, Vic, Australia
[2] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] In vivo vasopeptidase inhibition: Simultaneous inhibition of neutral endopeptidase and angiotensin converting enzyme by BMS-189921
    Hubner, RA
    Paxton, D
    Johnston, CI
    Burrell, LM
    JOURNAL OF HYPERTENSION, 2000, 18 : S13 - S13
  • [2] In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor
    Burrell, LM
    Rockell, MD
    Powell, J
    Johnston, CI
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 119A - 119A
  • [3] In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat
    Hubner, RA
    Kubota, E
    Casley, DJ
    Johnston, CI
    Burrell, LM
    JOURNAL OF HYPERTENSION, 2001, 19 (05) : 941 - 946
  • [4] Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo
    Bäcklund, T
    Palojoki, E
    Grönholm, T
    Eriksson, A
    Vuolteenaho, O
    Laine, M
    Tikkanen, I
    PHARMACOLOGICAL RESEARCH, 2001, 44 (05) : 411 - 418
  • [5] Asymmetric synthesis of the vasopeptidase inhibitor BMS-189921
    Kronenthal, DR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U147 - U147
  • [6] Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats
    Campbell, DJ
    Anastasopoulos, F
    Duncan, AM
    James, GM
    Kladis, A
    Briscoe, TA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (02): : 567 - 577
  • [7] Efficient asymmetric synthesis of the vasopeptidase inhibitor BMS-189921
    Singh, J
    Kronenthal, DR
    Schwinden, M
    Godfrey, JD
    Fox, R
    Vawter, EJ
    Zhang, B
    Kissick, TP
    Patel, B
    Mneimne, O
    Humora, M
    Papaioannou, CG
    Szymanski, W
    Wong, MKY
    Chen, CK
    Heikes, JE
    DiMarco, JD
    Qiu, J
    Deshpande, RP
    Gougoutas, JZ
    Mueller, RH
    ORGANIC LETTERS, 2003, 5 (17) : 3155 - 3158
  • [8] Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed
    Dumoulin, MJ
    Adam, A
    Rouleau, JL
    Lamontagne, D
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (04) : 359 - 366
  • [9] Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes
    Anastasopoulos, F
    Leung, R
    Kladis, A
    James, GM
    Briscoe, TA
    Gorski, TP
    Campbell, DJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (03): : 799 - 805
  • [10] CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme
    Battistini, Bruno
    Daull, Philippe
    Jeng, Arco Y.
    CARDIOVASCULAR DRUG REVIEWS, 2005, 23 (04): : 317 - 330
12345